Fairvalue-Calculator Fairvalue-Calculator
EN DE

AViTA Corporation (4735) Fair Value & Analysis

Healthcare · TW · Market cap 1.3B TWD

Price30.30 TWD
Fair Value40.21 TWD
Upside+32.7%
Quality95/100
Evidence: Medium Range 28.15 TWD – 52.28 TWD

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

AViTA Corporation (4735) currently trades at 30.30 TWD, while our model-based Fair Value estimate is 40.21 TWD — implying the stock looks roughly 32.7% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

AViTA Corporation engages in the research, development, manufacturing, and sales of home healthcare products. Its products include non-contact thermometer, infrared ear/forehead thermometer, infrared ear thermometer, wrist type blood pressure monitor, arm type blood pressure monitor, nasal aspirator, nebulizer, electronic breast pump, pulse oximeter, and electronic lice comb. AViTA Corporation was founded in 1996 and is headquartered in New Taipei City, Taiwan.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -95% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -11% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is AViTA Corporation (4735) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 40.21 TWD versus a price of 30.30 TWD — about +33% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 4735?
Our 21-model fair value for AViTA Corporation is 40.21 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 30.30 TWD.
What is the quality score of 4735?
AViTA Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.